アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

direct rx - terbinafine hydrochloride (unii: 012c11zu6g) (terbinafine - unii:g7riw8s0xp) - terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (koh) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis. terbinafine tablets are contraindicated in patients with: chronic or active liver disease [see warnings and precautions (5.1)] history of allergic reaction to oral terbinafine because of the risk of anaphylaxis [see adverse reactions (6.2)] 8.1 pregnancy risk summary available data from postmarketing cases on the use of terbinafine tablets in pregnant women are insufficient to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies, terbinafine did not cause malformations or any harm to the fetus when administered to pregnant rabbits and rats during the period of or

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - terbinafine hydrochloride (unii: 012c11zu6g) (terbinafine - unii:g7riw8s0xp) - terbinafine tablets, usp are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (koh) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis. terbinafine tablets are contraindicated in patients with: •  history of allergic reaction to oral terbinafine because of the risk of anaphylaxis [see adverse reactions (6.2)] •  chronic or active liver disease [see warnings and precautions (5.1)] risk summary available data from postmarketing cases on the use of terbinafine tablets in pregnant women are insufficient to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies, terbinafine did not cause malformations or any harm to the fetus when administered to pregnant rabbits and rats during the period of organogenesis at oral d

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - terbinafine hydrochloride -

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - terbinafine hydrochloride, quantity: 10 mg/g - cream - excipient ingredients: isopropyl myristate; cetyl alcohol; sodium hydroxide; stearyl alcohol; benzyl alcohol; cetyl palmitate; polysorbate 60; sorbitan monostearate; purified water - treatment of ringworm (tinea corporis, tinea cruris and tinea pedis) caused by dermatophytes such as trichophyton (e.g. t. rubrum, t.mentagrophytes,,t.verrucosum, t.biolaceum), microsporum canis, and epidermophyton floccosum. cutaneous candidiasis.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - terbinafine hydrochloride, quantity: 281.25 mg (equivalent: terbinafine, qty 250 mg) - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; hypromellose; potato starch; magnesium stearate; sodium starch glycollate - treatment of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infection caused by dermatophytes such as trichophyton (e.g. t. rubrum, t.mentagrophytes, t.verrucosum, t.violaceum), microsporum canis and epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to other available treatments. onychomycosis (fungal infection of the nail) caused by dermatophyte fungi.

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

somex pharma - terbinafine hydrochloride - oral tablet - 250mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

relonchem ltd - terbinafine hydrochloride - oral tablet - 250mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - terbinafine hydrochloride - oral tablet - 250mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - terbinafine hydrochloride - oral tablet - 250mg

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - terbinafine hydrochloride (unii: 012c11zu6g) (terbinafine - unii:g7riw8s0xp) - antifungal - cures most athlete's foot (tinea pedis) - cures most jock itch (tinea cruris) and ringworm (tinea corporis) - relieves itching, burning, cracking and scaling which accompany these conditions